Clonal spread of imipenem-resistant Pseudomonas aeruginosa in the intensive care unit of a Turkish hospital

Journal of Chemotherapy

Volumn 13, Issue 5, 2001, Pages 546-554

  Gulay Z ^a   Atay, T ^a   Amyes, S G B ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Imipenem resistance; Intensive care; Nosocomial infection; Pseudomonas aeruginosa; Risk factors

Indexed keywords

AMIKACIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; GANCICLOVIR; GENTAMICIN; IMIPENEM; MEROPENEM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MALE; PSEUDOMONAS AERUGINOSA;

EID: 0034778707     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.5.546     Document Type: Article

References (26)

1. Pseudomonas aeruginosa
2. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gramnegative bacteria
3. Genetic definition of the substrate selectivity of Pseudomonas aeruginosa outer membrane porin protein Opr D
4. A functional classification scheme for β-lactamases and its correlation with molecular structure
5. Imipenem resistance among Gram-negative bacilli
6. Carbapenem hydrolyzing β-lactamases
7. Multifocal outbreaks of metallo beta-lactamase producing Pseudomonas aeruginosa resistant to broad spectrum beta-lactams including carbapenems
8. Imipenem induced resistance to antipseudomonal β-lactams in Pseudomonas aeruginosa
9. Beta-lactam resistance in aerobic commensal faecal flora
10. The use of analytical isoelectric focusing for detection and identification of β-lactamases
11. ARI-1, β-lactamase mediated imipenem resistance in Acinetobacter baumannii
12. IMP) in Gram-negative rods resistant to broad-spectrum β-lactams
13. Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: Criteria for bacterial strain typing
14. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit
15. The changing epidemiology of severe infections in the ICU
16. Epidemiology and clinical outcomes of patients with multi-resistant Pseudomonas aeruginosa
17. Emergence of resistance to beta-lactam agents in Pseudomonas aeruginosa with group I beta-lactamase in Spain
18. Carbapenem activities against Pseudomonas aeruginosa: Respective contributions of OprD and efflux systems
19. OXA-11, an extended-spectrum variant of OXA-10 (PSE2) β-lactamase from Pseudomonas aeruginosa
20. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa
21. Characterization of a novel extended spectrum β-lactamase from Pseudomonas aeruginosa
22. Widespread detection of PER-1 type extended spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa strains in Turkey: A nationwide multicenter study
23. Assessment of bacterial cross-transmission as a cause of infection in patients in intensive care units
24. Molecular epidemiology of ceftazidime-resistant Gram-negative bacilli on inanimate surfaces and their role in cross-transmission during nonoutbreak periods